Assets in USD of China SXT Pharmaceuticals, Inc. from Q1 2018 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
China SXT Pharmaceuticals, Inc. quarterly Assets history and change rate from Q1 2018 to Q1 2025.
  • China SXT Pharmaceuticals, Inc. Assets for the quarter ending 31 Mar 2025 was $21,663,508.000, a 6.33% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $21,663,508 -$1,463,549 -6.3% 31 Mar 2025 20-F 31 Jul 2025
Q3 2024 $30,997,352 +$16,409,371 +1.1% 30 Sep 2024 6-K 28 Mar 2025
Q1 2024 $23,127,057 -$6,426,999 -21.7% 31 Mar 2024 20-F 31 Jul 2025
Q3 2023 $14,587,981 -$7,593,377 -34.2% 30 Sep 2023 6-K 05 Apr 2024
Q1 2023 $29,554,056 -$3,992,217 -11.9% 31 Mar 2023 20-F 13 Aug 2024
Q3 2022 $22,181,358 -$489,102 -2.2% 30 Sep 2022 6-K 24 Feb 2023
Q1 2022 $33,546,273 -$1,001,329 -2.9% 31 Mar 2022 20-F 31 Jul 2023
Q3 2021 $22,670,460 -$1,372,411 -5.7% 30 Sep 2021 6-K 14 Jan 2022
Q1 2021 $34,547,602 +$12,845,424 +59.2% 31 Mar 2021 20-F/A 19 May 2023
Q3 2020 $24,042,871 +$996,928 +4.3% 30 Sep 2020 6-K 28 Jan 2021
Q1 2020 $21,702,178 +$4,231,345 +24.2% 31 Mar 2020 20-F 13 Aug 2021
Q3 2019 $23,045,943 30 Sep 2019 6-K/A 22 May 2020
Q1 2019 $17,470,833 +$9,812,939 +1.3% 31 Mar 2019 20-F 31 Jul 2020
Q1 2018 $7,657,894 31 Mar 2018 20-F 15 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.